Cargando…
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models
SIMPLE SUMMARY: DDX3X has been repeatedly proven to exert pro-tumorigenic effects in breast cancer. An inhibitor of DDX3X helicase function, FHP01, exhibited very effective antiproliferative and tumor killing activity in vitro and in vivo against several breast cancer cells, yet showed no systemic t...
Autores principales: | Gherardini, Lisa, Inzalaco, Giovanni, Imperatore, Francesco, D’Aurizio, Romina, Franci, Lorenzo, Miragliotta, Vincenzo, Boccuto, Adele, Calandro, Pierpaolo, Andreini, Matteo, Tarditi, Alessia, Chiariello, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507746/ https://www.ncbi.nlm.nih.gov/pubmed/34638314 http://dx.doi.org/10.3390/cancers13194830 |
Ejemplares similares
-
Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models
por: Brai, Annalaura, et al.
Publicado: (2021) -
The translational landscape as regulated by the RNA helicase DDX3
por: Park, Joon Tae, et al.
Publicado: (2022) -
Detection of Genomic Structural Variants from Next-Generation Sequencing Data
por: Tattini, Lorenzo, et al.
Publicado: (2015) -
Biological role of miR-204 and miR-211 in melanoma
por: Vitiello, Marianna, et al.
Publicado: (2018) -
Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation
por: Giraud, Guillaume, et al.
Publicado: (2018)